PCR-Based Detection of Priority Bacterial Biological Threat Agents: Advances in Diagnosis of Anthrax, Tularemia and Brucellosis
DOI:
https://doi.org/10.31073/onehealthjournal2026-IV-01Keywords:
One Health, polymerase chain reaction (PCR), real-time PCR (qPCR), multiplex PCR, digital PCR, Bacillus anthracis, Francisella tularensis, Brucella spp., biosurveillance, biodefense, molecular diagnostics, biological threat agentsAbstract
The rapid and accurate detection of high-consequence bacterial pathogens is essential for public health preparedness, veterinary medicine, food safety, and biodefense. Within the One Health framework, molecular diagnostics have become indispensable for integrated surveillance of zoonotic diseases affecting humans, animals, and the environment. This review summarizes current advances in polymerase chain reaction (PCR)-based detection of three priority bacterial biological threat agents: Bacillus anthracis, Francisella tularensis, and Brucella spp. The diagnostic principles, major genetic targets, specimen selection, and performance characteristics of conventional PCR, real-time quantitative PCR (qPCR), multiplex PCR, nested PCR, digital PCR (dPCR), and loop-mediated isothermal amplification (LAMP) are discussed. Particular attention is given to the role of multiplex molecular assays in the simultaneous detection and differentiation of biological threat agents, improving diagnostic speed, sensitivity, and laboratory biosafety. The review also highlights the expanding application of PCR technologies in biosurveillance, environmental monitoring, wildlife and vector surveillance, outbreak investigations, and laboratory preparedness for biological emergencies. Emerging innovations, including portable point-of-care PCR platforms, CRISPR-based diagnostics, whole-genome sequencing integration, artificial intelligence-assisted data interpretation, and cloud-based surveillance systems, are evaluated as future components of comprehensive biodefense strategies. Collectively, these technologies strengthen coordinated One Health surveillance by enabling rapid pathogen detection, improved epidemiological investigations, and timely response to naturally occurring outbreaks as well as deliberate biological threats, supporting global health security and modern laboratory preparedness.
References
Baily G. G., Krahn J. B., Drasar B. S., Stoker N. G. (1992). Detection of Brucella melitensis and Brucella abortus by DNA amplification. Journal of Tropical Medicine and Hygiene, 95(4), 271–275.
Bricker B. J., Halling S. M. (1994). Differentiation of Brucella abortus bv. 1, 2, and 4, Brucella melitensis, Brucella ovis, and Brucella suis bv. 1 by PCR. Journal of Clinical Microbiology, 32(11), 2660–2666. https://doi.org/10.1128/JCM.32.11.2660-2666.1994
Burkardt H.-J. (2000). Standardization and quality control of PCR analyses. Clinical Chemistry and Laboratory Medicine, 38(2), 87–91. https://doi.org/10.1515/CCLM.2000.014
Bustin S. A., Benes V., Garson J. A., Hellemans J., Huggett J., Kubista M., Mueller R., Nolan T., Pfaffl M. W., Shipley G. L., Vandesompele J., Wittwer C. T. (2009). The MIQE guidelines: Minimum information for publication of quantitative real-time PCR experiments. Clinical Chemistry, 55(4), 611–622. https://doi.org/10.1373/clinchem.2008.112797
Carlson C. J., Albery G. F., Merow C., Trisos C. H., Zipfel C. M., Eskew E. A., Olival K. J., Ross N., Bansal S. (2022). Climate change increases cross-species viral transmission risk. Nature, 607(7919), 555–562. https://doi.org/10.1038/s41586-022-04788-w
Centers for Disease Control and Prevention. (2023). Laboratory Response Network. https://www.cdc.gov/lrn
Chen J. S., Ma E., Harrington L. B., Da Costa M., Tian X., Palefsky J. M., Doudna J. A. (2018). CRISPR-Cas12a target binding unleashes indiscriminate single-stranded DNase activity. Science, 360(6387), 436–439. https://doi.org/10.1126/science.aar6245
Chiu C. Y., Miller S. A. (2019). Clinical metagenomics. Nature Reviews Genetics, 20(6), 341–355. https://doi.org/10.1038/s41576-019-0113-7
Dennis D. T., Inglesby T. V., Henderson D. A., Bartlett J. G., Ascher M. S., Eitzen E., Fine A. D., Friedlander A. M., Hauer J., Layton M., Lillibridge S. R., McDade J. E., Osterholm M. T., O'Toole T., Parker G., Perl T. M., Russell P. K., Tonat K. (2001). Tularemia as a biological weapon: Medical and public health management. JAMA, 285(21), 2763–2773. https://doi.org/10.1001/jama.285.21.2763
Destoumieux-Garzón D., Mavingui P., Boetsch G., Boissier J., Darriet F., Duboz P., Fritsch C., Giraudoux P., Le Roux F., Morand S., Paillard C., Pontier D., Sueur C., Voituron Y. (2018). The One Health concept: 10 years old and a long road ahead. Frontiers in Veterinary Science, 5, 14. https://doi.org/10.3389/fvets.2018.00014
Drain P. K., Hyle E. P., Noubary F. (2014). Diagnostic point-of-care tests in resource-limited settings. The Lancet Infectious Diseases, 14(3), 239–249. https://doi.org/10.1016/S1473-3099(13)70250-0
Easterday W. R., Van Ert M. N., Simonson T. S., Wagner D. M., Kenefic L. J., Allender C. J., Keim P. (2005). Use of single nucleotide polymorphisms in the plcR gene for specific identification of Bacillus anthracis. Journal of Clinical Microbiology, 43(4), 1995–1997. https://doi.org/10.1128/JCM.43.4.1995-1997.2005
Ellis J., Oyston P. C. F., Green M., Titball R. W. (2002). Tularemia. Clinical Microbiology Reviews, 15(4), 631–646. https://doi.org/10.1128/CMR.15.4.631-646.2002
Elnifro E. M., Ashshi A. M., Cooper R. J., Klapper P. E. (2000). Multiplex PCR: Optimization and application in diagnostic virology. Clinical Microbiology Reviews, 13(4), 559–570. https://doi.org/10.1128/CMR.13.4.559-570.2000
García-Yoldi D., Marín C. M., de Miguel M. J., Muñoz P. M., Vizmanos J. L., López-Goñi I. (2006). Multiplex PCR assay for the identification and differentiation of all Brucella species and the vaccine strains Brucella abortus S19 and RB51 and Brucella melitensis Rev1. Clinical Chemistry, 52(4), 779–781. https://doi.org/10.1373/clinchem.2005.062596
Godfroid J., Scholz H. C., Barbier T., Nicolas C., Wattiau P., Fretin D., Whatmore A. M., Cloeckaert A., Blasco J. M., Moriyón I., Saegerman C., Muma J. B., Al Dahouk S., Neubauer H., Letesson J.-J. (2011). Brucellosis at the animal/ecosystem/human interface at the beginning of the 21st century. Preventive Veterinary Medicine, 102(2), 118–131. https://doi.org/10.1016/j.prevetmed.2011.04.007
Gootenberg J. S., Abudayyeh O. O., Lee J. W., Essletzbichler P., Dy A. J., Joung J., Verdine V., Donghia N., Daringer N. M., Freije C. A., Myhrvold C., Bhattacharyya R. P., Livny J., Regev A., Koonin E. V., Hung D. T., Sabeti P. C., Collins J. J., Zhang F. (2017). Nucleic acid detection with CRISPR-Cas13a/C2c2. Science, 356(6336), 438–442. https://doi.org/10.1126/science.aam9321
Gwinn M., MacCannell D., Armstrong G. L. (2019). Next-generation sequencing of infectious pathogens. JAMA, 321(9), 893–894. https://doi.org/10.1001/jama.2018.21669
Hindson B. J., Ness K. D., Masquelier D. A., Belgrader P., Heredia N. J., Makarewicz A. J., Bright I. J., Lucero M. Y., Hiddessen A. L., Legler T. C., Kitano T. K., Hodel M. R., Petersen J. F., Wyatt P. W., Steenblock E. R., Shah P. H., Bousse L. J., Troup C. B., Mellen J. C., Colston B. W. (2011). High-throughput droplet digital PCR system for absolute quantitation of DNA copy number. Analytical Chemistry, 83(22), 8604–8610. https://doi.org/10.1021/ac202028g
Hoffmaster A. R., Meyer R. F., Bowen M. D., Marston C. K., Weyant R. S., Thurman K., Messenger S. L., Minor E. E., Winchell J. M., Popovic T. (2002). Evaluation and validation of a real-time PCR assay for rapid identification of Bacillus anthracis. Emerging Infectious Diseases, 8(10), 1178–1182. https://doi.org/10.3201/eid0810.020393
Huggett J. F., Cowen S., Foy C. A. (2015). Considerations for digital PCR as an accurate molecular diagnostic tool. Clinical Chemistry, 61(1), 79–88. https://doi.org/10.1373/clinchem.2014.221366
Inglesby T. V., O'Toole T., Henderson D. A., Bartlett J. G., Ascher M. S., Eitzen E., Friedlander A. M., Gerberding J. L., Hughes J., McDade J. E., Osterholm M. T., Parker G., Perl T. M., Russell P. K., Tonat K. (2002). Anthrax as a biological weapon, 2002: Updated recommendations for management. JAMA, 287(17), 2236–2252. https://doi.org/10.1001/jama.287.17.2236
Janse I., Hamidjaja R. A., Bok J. M., van Rotterdam B. J., van der Plas J. (2010). Development and comparison of multiplex real-time PCR assays for the detection of bacterial biothreat agents. Applied and Environmental Microbiology, 76(18), 6104–6112.
Jones K. E., Patel N. G., Levy M. A., Storeygard A., Balk D., Gittleman J. L., Daszak P. (2008). Global trends in emerging infectious diseases. Nature, 451(7181), 990–993. https://doi.org/10.1038/nature06536
Keim P. S., Johansson A., Wagner D. M. (2007). Molecular epidemiology, evolution, and ecology of Francisella. Annals of the New York Academy of Sciences, 1105, 30–66. https://doi.org/10.1196/annals.1409.011
Keim P. S., Van Ert M. N., Pearson T., Vogler A. J., Huynh L. Y., Wagner D. M. (2006). Anthrax molecular epidemiology and forensics. International Journal of Food Microbiology, 112(1), 4–11.
Kilpatrick A. M., Randolph S. E. (2012). Drivers, dynamics, and control of emerging vector-borne zoonotic diseases. The Lancet, 380(9857), 1946–1955. https://doi.org/10.1016/S0140-6736(12)61151-9
Kubista M., Andrade J. M., Bengtsson M., Forootan A., Jonák J., Lind K., Sindelka R., Sjöback R., Sjögreen B., Strömbom L., Ståhlberg A., Zoric N. (2006). The real-time polymerase chain reaction. Molecular Aspects of Medicine, 27(2–3), 95–125. https://doi.org/10.1016/j.mam.2005.12.007
Mackay I. M., Arden K. E., Nitsche A. (2002). Real-time PCR in virology. Nucleic Acids Research, 30(6), 1292–1305. https://doi.org/10.1093/nar/30.6.1292
Mock M., Fouet A. (2001). Anthrax. Annual Review of Microbiology, 55, 647–671. https://doi.org/10.1146/annurev.micro.55.1.647
Moreno E. (2014). Retrospective and prospective perspectives on zoonotic brucellosis. Frontiers in Microbiology, 5, 213. https://doi.org/10.3389/fmicb.2014.00213
Morse S. S., Mazet J. A. K., Woolhouse M., Parrish C. R., Carroll D., Karesh W. B., Zambrana-Torrelio C., Lipkin W. I., Daszak P. (2012). Prediction and prevention of the next pandemic zoonosis. The Lancet, 380(9857), 1956–1965. https://doi.org/10.1016/S0140-6736(12)61684-5
Notomi T., Okayama H., Masubuchi H., Yonekawa T., Watanabe K., Amino N., Hase T. (2000). Loop-mediated isothermal amplification of DNA. Nucleic Acids Research, 28(12), e63. https://doi.org/10.1093/nar/28.12.e63
Olsen S. C., Palmer M. V. (2014). Advancement of knowledge of Brucella over the past 50 years. Veterinary Pathology, 51(6), 1076–1089. https://doi.org/10.1177/0300985814540545
Pappas G., Akritidis N., Bosilkovski M., Tsianos E. (2005). Brucellosis. New England Journal of Medicine, 352(22), 2325–2336. https://doi.org/10.1056/NEJMra050570
Probert W. S., Schrader K. N., Khuong N. Y., Bystrom S. L., Graves M. H. (2004). Real-time multiplex PCR assay for detection of Brucella spp., Brucella abortus, and Brucella melitensis. Journal of Clinical Microbiology, 42(3), 1290–1293. https://doi.org/10.1128/JCM.42.3.1290-1293.2004
Quick J., Ashton P., Calus S., Chatt C., Gossain S., Hawker J., Nair S., Neal K., Nye K., Peters T., de Pinna E., Robinson E., Struthers K., Webber M., Wilcox M., Loman N. J. (2016). Rapid draft and real-time nanopore sequencing in a hospital outbreak of Salmonella. Genome Biology, 16, 114. https://doi.org/10.1186/s13059-015-0677-2
Sjöstedt A. (2007). Tularemia: History, epidemiology, pathogen physiology, and clinical manifestations. Annals of the New York Academy of Sciences, 1105, 1–29. https://doi.org/10.1196/annals.1409.009
Taylor L. H., Latham S. M., Woolhouse M. E. J. (2001). Risk factors for human disease emergence. Philosophical Transactions of the Royal Society B: Biological Sciences, 356(1411), 983–989. https://doi.org/10.1098/rstb.2001.0888
Turnbull P. C. B. (2008). Anthrax in Humans and Animals (4th ed.). World Health Organization.
Ip MCheuk E.S.C., Tsui M.H.Y., Kong F., Leung T.N., Gilbert G.L. (2006). Identification of a Streptococcus agalactiae Serotype III Subtype 4 Clone in Association with Adult Invasive Disease in Hong Kong. J Clin Microbiol44:.https://doi.org/10.1128/jcm.01533-06
Versage J. L., Severin D. D., Chu M. C., Petersen J. M. (2003). Development of a multitarget real-time TaqMan PCR assay for enhanced detection of Francisella tularensis in complex specimens. Journal of Clinical Microbiology, 41(12), 5492–5499. https://doi.org/10.1128/JCM.41.12.5492-5499.2003
Vogler A. J., Birdsell D., Price L. B., Bowers J. R., Beckstrom-Sternberg S. M., Auerbach R. K., Beckstrom-Sternberg J. S., Johansson A., Clare A., Buchhagen J. L., Petersen J. M., Pearson T., Vaissaire J., Dempsey M. P., Foxall P., Engelthaler D. M., Wagner D. M., Keim P. (2009). Phylogeography of Francisella tularensis: global expansion of a highly fit clone. Journal of bacteriology, 191(8), 2474–2484. https://doi.org/10.1128/JB.01786-08
Whatmore A. M., Koylass M. S., Muchowski J., Edwards-Smallbone J., Gopaul K. K., Perrett L. L. (2016). Extended multilocus sequence analysis to describe the global population structure of the genus Brucella: Phylogeography and relationship to biovars. Frontiers in Microbiology, 7, 2049. https://doi.org/10.3389/fmicb.2016.02049
World Health Organization, Food and Agriculture Organization of the United Nations, United Nations Environment Programme, World Organisation for Animal Health. (2022). One Health Joint Plan of Action (2022–2026).
World Health Organization. (2024). Laboratory Biosafety Manual (4th ed.). World Health Organization.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2026 One Health Journal

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.

